CYTK:NASDAQ
Cytokinetics, Inc.
$60.02
arrow_downward
-1.79%(-1.09) 1D
Oct 8, 12:13:39 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$60.31
High
$61.06
Low
$59.78
Mkt. cap
8.35B
Avg. vol.
2.19M
Volume
498.90K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$60.31
High
$61.06
Low
$59.78
Mkt. cap
8.35B
Avg. vol.
2.19M
Volume
498.90K
52-wk high
$88.31
52-wk low
$54.30
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
GuruFocus
·
27 minutes ago
CYTK Maintained by RBC Capital -- Price Target Raised to $113
AD HOC NEWS
·
13 hours ago
Cytokinetics stock heads into four HFSA presentations
Yahoo Finance
·
17 hours ago
Cytokinetics, Incorporated (CYTK) Stock Forecasts
Stock Traders Daily
·
1 day ago
(CYTK) Risk Channels and Responsive Allocation
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com